Showcase Your Science: Pipeline Innovation Partner Presentations

3:15 pm - Tuesday 28th April 2026

2nd Presentation Session

Present your company’s slides by securing a 15-minute presentation slot in front of the attending audience.

What is this session?

To host as many innovative companies as possible on day one, this second session opens more presenting opportunities in front of the attending audience.

Presentation Sessions Remaining

3.15Tinostamustine, a Novel Approach for the Treatment of Central Nervous System Cancers Presentation by Imbrium Therapeutics

3.30 Improved BBB Transport via Novel AAV Capsid Engineered to Bind to TfR1 Receptor Presentation by Exegenesis Bio

3.45 The Opportunity for Neflamapimod in Age-Related Brain Disorders Presentation by CervoMed

4.00 NUZ-001: An Investigational Oral Therapy in Phase 2/3 Clinical Development for ALS by Neurizon

4.15 Reimagining Levodopa Therapy with Minitablets & the OraFID Device by Navamedic

4.30 Risvodetinib as a Potential Disease Modifying Therapy for Neurodegenerative Disease by ABLi Therapeutics 

4.45 Presentation by Agene Bio

5.00 Presentation by Senovia Bioscience

5.15 MM-3001: A Fast-Onset, Long-Acting Therapeutic SLiP for Chronic Pain by Mimetic Medicines

Speakers:

Chief Commercial & Business Officer
CervoMed
Vice President International Business
Navamedic
Chief Scientific Officer
Imbrium Therapeutics
Chief Business Officer
Exegenesis Bio
Chairman & Chief Executive Officer
ABLi Therapeutics
Chief Executive Officer & Co- Founder
Mimetic Medicines
Scientific and Medical Partnership Lead
Neurizon